Vanda Pharmaceuticals Inc. · NASDAQ:VNDA
Duncan Charles Cliff received 41,600 Vanda Pharmaceuticals Inc. shares as an award (Form 4)
Traded Jun 4, 2026 · Filed Jun 8, 2026
On Jun 4, 2026, Duncan Charles Cliff (Director) received 41,600 Vanda Pharmaceuticals Inc. shares as an award, leaving 98,701 shares. Filed Jun 8, 2026 (Form 4).
- Awarded
- 41,600 shares
- Holding after
- 98,701 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Award | 41,600 | 98,701 | Direct |
Source
Related
- Vanda Pharmaceuticals Inc.
- Duncan Charles Cliff
- Vanda Pharmaceuticals Inc. shareholders
- Form 4 · Duncan Charles Cliff · Apr 24, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 9, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · McGuire Daniel Patrick · Jun 8, 2026
- Form 4 · Chrousos Phaedra · Jun 8, 2026